Kinesio-Taping and Chest Physiotherapy Program After Mastectomy

Not Applicable

Active, not recruiting

• Conditions: Mastectomy

• Registration Number: NCT06701591
• Lead Sponsor: Cairo University

Brief Summary

The modified radical mastectomy (MRM) is a major surgical approach that necessitates the dissection of axillary lymph nodes. As a result, there is more bleeding and the treatment takes longer time. This treatment is used to treat locally advanced breast cancer. Numerous factors, including pain and respiratory depression from general anaesthesia, can impair respiratory function during the post-operative period. Pain causes the thoracic cage's post-operative movement to be restricted and the breathing muscles to become inhibited.

Detailed Description

KT is a new technology that is being used in the treatment of post-surgical and respiratory problems, among other innovative evidence-based therapeutic options in patient care. Recently, this method is useful for treating a variety of sports-related and musculoskeletal disorders, as well as pain management. According to a small body of research on the usefulness and efficacy of KT in treating respiratory conditions in patients with chronic obstructive pulmonary disease (COPD), it can lead to improvements in respiratory muscle strength and pulmonary function.

Study Timeline

• Study First Submitted: 2024-11-20
• Study First Submitted QC: 2024-11-20
• Study First Posted: 2024-11-22
• Status Verified: 2024-12
• Study Start: 2024-12-20
• Last Update Submitted: 2025-01-24
• Last Update Posted: 2025-01-28
• Primary Completion: 2025-06-30
• Study Completion: 2025-07-30

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• Females aged between 30 and 50 years
• Participants after modified radical mastectomy
• Participants able to comprehend instructions.
• Cooperative participants, and willing to participate in the study.

Exclusion Criteria

• Participants having sensitive skin, scars, or lesions.
• Participants with unhealed incisions at the site of application.
• Participants with uncontrolled diabetes.
• Participants with deep vein thrombosis.
• Participants with previous chest diseases.
• Pregnancy.
• Participants with altered sensations.
• Participants with allodynia.
• Participants with active infection.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
visual analogue scale	4 weeks	The visual representation of the pain range that a patient thinks they might experience is called a linear scale. The score is ranged from 0 to 10. The least the score, the better results. While, the higher the score, the worst the results.

Secondary Outcome Measures

Name	Time	Method
Forced vital capacity (FVC)	4 weeks	The forced vital capacity (FVC) will be measured by spirometer.
forced expiratory volume at first second (FEV1)	4 weeks	forced expiratory volume at first second (FEV1) will be measured by spirometer.
Forced expiratory volume at first second /Forced vital capacity ratio.	4 weeks	Forced expiratory volume at first second /Forced vital capacity ratio will be measured by spirometer.
Respiratory muscle strength	4 weeks	Respiratory muscle strength will be measured by assessing the maximal inspiratory and maximal expiratory pressures (MIP) and maximal expiratory pressures (MEP).
Quality of life	4 weeks	Quality of life will be measured by the Short Form-36 (SF-36). It is a questionnaire with eight subscales that gives information about the health status and quality of life of the person. Scores on each subscale range from 0 to 100, with 0 corresponding to the worst health status and 100 to the best health status.

Trial Locations

Locations (1)

Faculty of physical therapy; 🇪🇬 Giza, Egypt